Literature DB >> 25822926

Guiding principles in the design of molecular bioconjugates for vaccine applications.

Haipeng Liu1,2,3, Darrell J Irvine4.   

Abstract

Antigen- and adjuvant-based bioconjugates that can stimulate the immune system play an important role in vaccine applications. Bioconjugates have demonstrated unique physicochemical and biological properties, enabling vaccines to be delivered to key immune cells, to target specific intracellular pathways, or to mimic immunogenic properties of natural pathogens. In this Review we highlight recent advances in such molecular immunomodulators, with an emphasis on the structure-function relationships that provide the foundation for rational design of safe and effective vaccines and immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25822926      PMCID: PMC4694040          DOI: 10.1021/acs.bioconjchem.5b00103

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  114 in total

1.  New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

Authors:  E R Brandt; K S Sriprakash; R I Hobb; W A Hayman; W Zeng; M R Batzloff; D C Jackson; M F Good
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

Review 3.  An overview of adjuvant formulations and delivery systems.

Authors:  Alexis García; Juan B De Sanctis
Journal:  APMIS       Date:  2013-08-06       Impact factor: 3.205

4.  The age of vaccines.

Authors:  Tony Scully
Journal:  Nature       Date:  2014-03-06       Impact factor: 49.962

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

6.  The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.

Authors:  Jianjun Chen; Rebecca R Pompano; Felix W Santiago; Lea Maillat; Roger Sciammas; Tao Sun; Huifang Han; David J Topham; Anita S Chong; Joel H Collier
Journal:  Biomaterials       Date:  2013-08-13       Impact factor: 12.479

7.  A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.

Authors:  Milaid Granadillo; Maribel G Vallespi; Aileen Batte; Osmany Mendoza; Yordanka Soria; Victoria M Lugo; Isis Torrens
Journal:  Vaccine       Date:  2010-12-09       Impact factor: 3.641

Review 8.  Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.

Authors:  Sandip K Datta; Hearn J Cho; Kenji Takabayashi; Anthony A Horner; Eyal Raz
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

9.  Why certain dyes are useful for localizing the sentinel lymph node.

Authors:  Chris Tsopelas; Richard Sutton
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

10.  A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

Authors:  Zoe Hunter; Derrick P McCarthy; Woon Teck Yap; Christopher T Harp; Daniel R Getts; Lonnie D Shea; Stephen D Miller
Journal:  ACS Nano       Date:  2014-02-27       Impact factor: 15.881

View more
  26 in total

1.  Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.

Authors:  Myunggi An; Chunsong Yu; Jingchao Xi; Joyce Reyes; Guangzhao Mao; Wei-Zen Wei; Haipeng Liu
Journal:  Nanoscale       Date:  2018-05-17       Impact factor: 7.790

2.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.

Authors:  Chunsong Yu; Myunggi An; Evan Jones; Haipeng Liu
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

Review 4.  Strategies for designing synthetic immune agonists.

Authors:  Tom Y-H Wu
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

5.  Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Riley Allen; Lisa M Mahakian; Sarah M Tam; Hua Zhang; Matthew T Silvestrini; Jamal S Lewis; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2017-10-13       Impact factor: 4.774

Review 6.  Nanomedicine approaches to improve cancer immunotherapy.

Authors:  Hui Qiu; Yuanzeng Min; Zach Rodgers; Longzhen Zhang; Andrew Z Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-10

7.  Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy.

Authors:  Weidong Zhang; Myunggi An; Jingchao Xi; Haipeng Liu
Journal:  Bioconjug Chem       Date:  2017-07-06       Impact factor: 4.774

Review 8.  Engineering opportunities in cancer immunotherapy.

Authors:  Laura Jeanbart; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

9.  Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis.

Authors:  Qian Zhong; Elizabeth R Bielski; Leonan S Rodrigues; Matthew R Brown; Joshua J Reineke; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2016-06-10       Impact factor: 4.939

10.  Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.

Authors:  Qian Zhong; Olivia M Merkel; Joshua J Reineke; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2016-05-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.